QuantumScape’s third quarter showed lower spending, a narrower loss, and a smaller cash balance than a year earlier, while ...

Greene County Bancorp reported record quarterly net income of $12.5 million for the three months ended Sept. 30, 2026, up ...

Confluent, Inc. has recently released its 10-Q report, providing a detailed look into the company's financial performance and operational activities. Confluent operates a data streaming platform, ...

Apple Inc. has released its 2025 Form 10-K, revealing key financial and operational insights from the fiscal year ending September 27, 2025. The report highlights the company's product, service, and ...

Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) has entered into a global exclusive development and commercialization license agreement with Novartis to advance Vav1 Molecular Glue Degraders (MGDs), ...

Neumora Therapeutics, Inc. (NASDAQ: NMRA) has recently announced the initiation of a phase 1 single-ascending dose/multiple-ascending dose (SAD/MAD) study of NMRA-898, a structurally distinct M4 ...

Kraft Heinz Company (NASDAQ: KHC) has reported its financial results for the third quarter of 2025. The company's net sales decreased by 2.3% to $6.2 billion, with organic net sales declining by 2.5%.

Huntington Bancshares Incorporated has announced its definitive agreement to acquire Cadence Bank, a $53 billion regional bank headquartered in Houston, Texas and Tupelo, Mississippi. This acquisition ...

Dianthus Therapeutics, a clinical-stage biotechnology company, has recently released its 10-K report, detailing its operations and financial performance. The company, founded in 2019 and headquartered ...

Jazz Pharmaceuticals completed its acquisition of Actio Biosciences for $820 million upfront, adding ABS-1230, a clinical-stage epilepsy drug candidate, to its rare disease portfolio. For Jazz, the ...

Keurig Dr Pepper said it will receive $925 million in pre-tax proceeds from a pair of transactions with Chobani, including the sale of its minority stake in Chobani for $800 million and the sale of ...

Cormedix Therapeutics said the U.S. Court of Appeals for the Federal Circuit upheld a district court ruling that its Minocin for Injection patents are valid and infringed, preserving an injunction ...